Thomas Loustau

6PUBLICATIONS
39CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Agricultural molecular engineering of nucleic acids and proteinsMolecular targetsPredictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 31, 2026
Tenascin-C orchestrates radiotherapy-induced head and neck tumor regression.

Thomas Loustau, Ioanna Mitrentsi, Nuohan Wang

|Jan 28, 2026
Antimicrobial Resistance: How Can We Overcome the Problem?

Valerio Massimo Sora, Clementine Wallet, Gabriele Meroni

|Oct 09, 2024
Targeting the MAtrix REgulating MOtif abolishes several hallmarks of cancer, triggering antitumor immunity.

Chengbei Li, Amanpreet Kaur, Alexia Pavlidaki

|May 13, 2023
Investigating Chemokine-Matrix Networks in Breast Cancer: Tenascin-C Sets the Tone for CCL2.

Martha Gschwandtner, Anís N Gammage, Claire Deligne

|Sep 14, 2022
Advances on the roles of tenascin-C in cancer.

Alev Yilmaz, Thomas Loustau, Nathalie Salomé

|May 14, 2021
Tenascin-C immobilizes infiltrating T lymphocytes through CXCL12 promoting breast cancer progression.

Devadarssen Murdamoothoo, Zhen Sun, Alev Yilmaz

Pageof 1

Frequent Collaborators

5 joint publications

Gertraud Orend

4 joint publications

Raphael Carapito

3 joint publications

Manuel Koch

2 joint publications

Nathalie Salomé